Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

PNAS 103 (15): 5989-5994

Copyright © 2006 by the National Academy of Sciences.

From the Cover


BIOLOGICAL SCIENCES / MICROBIOLOGY

Ligand-induced and nonfusogenic dissolution of a viral membrane

Mansun Law*,{dagger}, Gemma C. Carter*, Kim L. Roberts, Michael Hollinshead, and Geoffrey L. Smith{ddagger}

Department of Virology, Faculty of Medicine, Imperial College London, St. Mary’s Campus, Norfolk Place, London W2 1PG, United Kingdom

Communicated by Bernard Moss, National Institutes of Health, Bethesda, MD, February 7, 2006

Received for publication January 9, 2006.

Abstract: Hitherto, all enveloped viruses were thought to shed their lipid membrane during entry into cells by membrane fusion. The extracellular form of Vaccinia virus has two lipid envelopes surrounding the virus core, and consequently a single fusion event will not deliver a naked core into the cell. Here we report a previously underscribed mechanism in which the outer viral membrane is disrupted by a ligand-induced nonfusogenic reaction, followed by the fusion of the inner viral membrane with the plasma membrane and penetration of the virus core into the cytoplasm. The dissolution of the outer envelope depends on interactions with cellular polyanionic molecules and requires the virus glycoproteins A34 and B5. This discovery represents a remarkable example of how viruses manipulate biological membranes, solves the topological problem of how a double-enveloped virus enters cells, reveals a new effect of polyanions on viruses, and provides a therapeutic approach for treatment of poxvirus infections, such as smallpox.

Key Words: antiviral therapy • extracellular enveloped virus • membrane dissolution • Vaccinia virus • virus entry


Freely available online through the PNAS open access option.

*M.L. and G.C.C. contributed equally to this work.

{dagger}Present address: Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037.

Author contributions: M.L., G.C.C., K.L.R., M.H., and G.L.S. designed research; M.L., G.C.C., K.L.R., and M.H. performed research; M.L., G.C.C., K.L.R., M.H., and G.L.S. analyzed data; and M.L., G.C.C., and G.L.S. wrote the paper.

Conflict of interest statement: No conflicts declared.

{ddagger}To whom correspondence should be addressed. E-mail: glsmith{at}imperial.ac.uk

© 2006 by The National Academy of Sciences of the USA


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
TRAF2 Facilitates Vaccinia Virus Replication by Promoting Rapid Virus Entry.
I. R. Haga, T. Pechenick Jowers, S. J. Griffiths, J. Haas, and P. M. Beard (2014)
J. Virol. 88, 3664-3677
   Abstract »    Full Text »    PDF »
CD4+ T Cells Provide Intermolecular Help To Generate Robust Antibody Responses in Vaccinia Virus-Vaccinated Humans.
L. Yin, J. M. Calvo-Calle, J. Cruz, F. K. Newman, S. E. Frey, F. A. Ennis, and L. J. Stern (2013)
J. Immunol. 190, 6023-6033
   Abstract »    Full Text »    PDF »
Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions.
V. Doceul, M. Hollinshead, A. Breiman, K. Laval, and G. L. Smith (2012)
J. Gen. Virol. 93, 1876-1886
   Abstract »    Full Text »    PDF »
Increased Interaction between Vaccinia Virus Proteins A33 and B5 Is Detrimental to Infectious Extracellular Enveloped Virion Production.
W. M. Chan and B. M. Ward (2012)
J. Virol. 86, 8232-8244
   Abstract »    Full Text »    PDF »
Vaccinia Mature Virus Fusion Regulator A26 Protein Binds to A16 and G9 Proteins of the Viral Entry Fusion Complex and Dissociates from Mature Virions at Low pH.
S.-J. Chang, A.-C. Shih, Y.-L. Tang, and W. Chang (2012)
J. Virol. 86, 3809-3818
   Abstract »    Full Text »    PDF »
Mutagenesis of the palmitoylation site in vaccinia virus envelope glycoprotein B5.
M. M. Lorenzo, J. M. Sanchez-Puig, and R. Blasco (2012)
J. Gen. Virol. 93, 733-743
   Abstract »    Full Text »    PDF »
DNA-PK is a DNA sensor for IRF-3-dependent innate immunity.
B. J. Ferguson, D. S. Mansur, N. E. Peters, H. Ren, and G. L. Smith (2012)
eLife Sci 1, e00047
   Abstract »    Full Text »    PDF »
The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins.
B. C. DeHaven, K. Gupta, and S. N. Isaacs (2011)
J. Gen. Virol. 92, 1971-1980
   Abstract »    Full Text »    PDF »
Vaccinia extracellular virions enter cells by macropinocytosis and acid-activated membrane rupture.
F. I. Schmidt, C. K. E. Bleck, A. Helenius, and J. Mercer (2011)
EMBO J. 30, 3647-3661
   Abstract »    Full Text »    PDF »
Vaccinia virus B5 protein affects the glycosylation, localization and stability of the A34 protein.
A. Breiman and G. L. Smith (2010)
J. Gen. Virol. 91, 1823-1827
   Abstract »    Full Text »    PDF »
Characterization of a Newly Identified 35-Amino-Acid Component of the Vaccinia Virus Entry/Fusion Complex Conserved in All Chordopoxviruses.
P. S. Satheshkumar and B. Moss (2009)
J. Virol. 83, 12822-12832
   Abstract »    Full Text »    PDF »
Appraising the apoptotic mimicry model and the role of phospholipids for poxvirus entry.
J. P. Laliberte and B. Moss (2009)
PNAS 106, 17517-17521
   Abstract »    Full Text »    PDF »
Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane.
K. L. Roberts, A. Breiman, G. C. Carter, H. A. Ewles, M. Hollinshead, M. Law, and G. L. Smith (2009)
J. Gen. Virol. 90, 1582-1591
   Abstract »    Full Text »    PDF »
Investigation of orf virus structure and morphogenesis using recombinants expressing FLAG-tagged envelope structural proteins: evidence for wrapped virus particles and egress from infected cells.
J. L. Tan, N. Ueda, A. A. Mercer, and S. B. Fleming (2009)
J. Gen. Virol. 90, 614-625
   Abstract »    Full Text »    PDF »
Expression of the A56 and K2 Proteins Is Sufficient To Inhibit Vaccinia Virus Entry and Cell Fusion.
T. R. Wagenaar and B. Moss (2009)
J. Virol. 83, 1546-1554
   Abstract »    Full Text »    PDF »
Vaccinia Virus L1 Protein Is Required for Cell Entry and Membrane Fusion.
H. Bisht, A. S. Weisberg, and B. Moss (2008)
J. Virol. 82, 8687-8694
   Abstract »    Full Text »    PDF »
A Conserved Sequence within the H2 Subunit of the Vaccinia Virus Entry/Fusion Complex Is Important for Interaction with the A28 Subunit and Infectivity.
G. E. Nelson, T. R. Wagenaar, and B. Moss (2008)
J. Virol. 82, 6244-6250
   Abstract »    Full Text »    PDF »
Vaccinia Virus A56/K2 Fusion Regulatory Protein Interacts with the A16 and G9 Subunits of the Entry Fusion Complex.
T. R. Wagenaar, S. Ojeda, and B. Moss (2008)
J. Virol. 82, 5153-5160
   Abstract »    Full Text »    PDF »
The Vaccinia Virus B5 Protein Requires A34 for Efficient Intracellular Trafficking from the Endoplasmic Reticulum to the Site of Wrapping and Incorporation into Progeny Virions.
A. K. Earley, W. M. Chan, and B. M. Ward (2008)
J. Virol. 82, 2161-2169
   Abstract »    Full Text »    PDF »
Vaccinia Virus A34 Glycoprotein Determines the Protein Composition of the Extracellular Virus Envelope.
B. Perdiguero, M. M. Lorenzo, and R. Blasco (2008)
J. Virol. 82, 2150-2160
   Abstract »    Full Text »    PDF »
Exposure of ichnovirus particles to digitonin leads to enhanced infectivity and induces fusion from without in an in vitro model system.
D. Stoltz, R. Lapointe, A. Makkay, and M. Cusson (2007)
J. Gen. Virol. 88, 2977-2984
   Abstract »    Full Text »    PDF »
Characterization of Chimpanzee/Human Monoclonal Antibodies to Vaccinia Virus A33 Glycoprotein and Its Variola Virus Homolog In Vitro and in a Vaccinia Virus Mouse Protection Model.
Z. Chen, P. Earl, J. Americo, I. Damon, S. K. Smith, F. Yu, A. Sebrell, S. Emerson, G. Cohen, R. J. Eisenberg, et al. (2007)
J. Virol. 81, 8989-8995
   Abstract »    Full Text »    PDF »
Two Distinct Low-pH Steps Promote Entry of Vaccinia Virus.
A. C. Townsley and B. Moss (2007)
J. Virol. 81, 8613-8620
   Abstract »    Full Text »    PDF »
Association of Vaccinia Virus Fusion Regulatory Proteins with the Multicomponent Entry/Fusion Complex.
T. R. Wagenaar and B. Moss (2007)
J. Virol. 81, 6286-6293
   Abstract »    Full Text »    PDF »
Sequence-Independent Targeting of Transmembrane Proteins Synthesized within Vaccinia Virus Factories to Nascent Viral Membranes.
M. Husain, A. S. Weisberg, and B. Moss (2007)
J. Virol. 81, 2646-2655
   Abstract »    Full Text »    PDF »
Vaccinia Virus F9 Virion Membrane Protein Is Required for Entry but Not Virus Assembly, in Contrast to the Related L1 Protein.
E. Brown, T. G. Senkevich, and B. Moss (2006)
J. Virol. 80, 9455-9464
   Abstract »    Full Text »    PDF »
Vaccinia Virus G9 Protein Is an Essential Component of the Poxvirus Entry-Fusion Complex.
S. Ojeda, A. Domi, and B. Moss (2006)
J. Virol. 80, 9822-9830
   Abstract »    Full Text »    PDF »
Flavivirus membrane fusion..
K. Stiasny and F. X. Heinz (2006)
J. Gen. Virol. 87, 2755-2766
   Abstract »    Full Text »    PDF »
Vaccinia Virus Entry into Cells via a Low-pH-Dependent Endosomal Pathway.
A. C. Townsley, A. S. Weisberg, T. R. Wagenaar, and B. Moss (2006)
J. Virol. 80, 8899-8908
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882